生物制剂和靶向合成疗法时代类风湿性关节炎的管理和治疗结果：对KURAMA队列10年数据的评估

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis.2006 · 239 citations
2. 2Trends in Adverse Event Rates in Hospitalized Patients, 2010-20192022 · 105 citations
3. 3Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort2018 · 84 citations
4. 4A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomized controlled trial2009 · 101 citations
5. 5Ten years with biologics: to whom do data on effectiveness and safety apply?2010 · 91 citations